The role of psychedelics in palliative care reconsidered: A case for psilocybin

OPEN Foundation
December 1, 2016

Kelmendi, B., Corlett, P., Ranganathan, M., D’Souza, C., & Krystal, J. H. (2016). The role of psychedelics in palliative care reconsidered: A case for psilocybin. Journal of psychopharmacology (Oxford, England), 30(12), 1212. 10.1177/0269881116675781
Link to full text

OPEN Foundation

Share This Post

get the latest

The OPEN Minded Newsletter keeps you informed about the latest psychedelic research & news, articles, exclusive events, job opportunities, programmes, and free resources!

By clicking SUBSCRIBE, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

Recent articles & news

Psilocybin and Neuroplasticity: A Review of Preclinical and Clinical Studies

The Global Psychedelic Survey 2025: A Study of International Naturalistic Psychedelic Use

Who Benefits from the Psychedelic Renaissance?

Psychedelics and Autonomy – From the Field

Affect and Psychedelic Therapy: From Raw Emotion to Narrative Memory

An Open Letter Reply to Dr. Stan Grof

Psychedelics and Nature – From the Field

Music in Psychedelic Practices – From the Field

Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions